Literature DB >> 29909934

Community pharmacies as access points for addiction treatment.

Kevin A Look1, Mercedes Kile2, Katie Morgan2, Andrew Roberts3.   

Abstract

BACKGROUND: There is growing interest in utilizing community pharmacies to support opioid abuse prevention and addiction treatment efforts. However, it is unknown whether the placement of community pharmacies is conducive to taking on such a role.
OBJECTIVE: To examine the distribution of community pharmacies in Wisconsin and its relationship with the location of addiction treatment facilities and opioid-related overdose events in rural and urban areas.
METHODS: The total number of opioid-related overdose deaths and crude death rates per 100,000 population were determined for each county in Wisconsin. Substance abuse treatment facilities were identified in each county to estimate access to formal addiction treatment. A list of pharmacies in the state was screened to identify community pharmacies in each county. Descriptive statistics and Pearson correlation coefficients were used to describe the distribution of and relationships between county-level opioid-related overdose death rates and the number of treatment facilities and community pharmacies in the state.
RESULTS: Wisconsin has 72 counties, of which 45 (62.5%) are classified as rural. Although the number of opioid-related overdose deaths was highly concentrated in urban areas, crude death rates per 100,000 population were similar in urban and rural areas. Rural counties were significantly less likely to have formal substance abuse treatment facilities (r = -.42, P = .00) or community pharmacies (r = -.44, P = .00) compared to urban counties. However, community pharmacies were more prevalent and more likely to be located in rural counties with higher rates of opioid-related overdose deaths than substance abuse treatment facilities. All but 1 of the 14 counties without a formal substance abuse treatment facility had access to 1 or more community pharmacies.
CONCLUSIONS: Community pharmacies are ideally located in areas that could be used to support medication-assisted addiction treatment efforts, particularly in rural areas lacking formal substance abuse treatment facilities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Access to care; Drug abuse; Pharmacy; Policy; Rural

Mesh:

Substances:

Year:  2018        PMID: 29909934      PMCID: PMC6433531          DOI: 10.1016/j.sapharm.2018.06.006

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  25 in total

1.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.

Authors:  Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

2.  Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.

Authors:  Andrew W Roberts; Delesha M Carpenter; Austin Smith; Kevin A Look
Journal:  Res Social Adm Pharm       Date:  2018-04-05

3.  Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.

Authors:  Abhijit S Gadkari; David A Mott; David H Kreling; Joseph K Bonnarens
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Sep-Oct

4.  Factors associated with provision of addiction treatment information by community pharmacists.

Authors:  Nicholas E Hagemeier; Arsham Alamian; Matthew M Murawski; Robert P Pack
Journal:  J Subst Abuse Treat       Date:  2014-11-21

5.  Issues Confronting Rural Pharmacies after a Decade of Medicare Part D.

Authors:  Fred Ullrich; Abiodun Salako; Keith Mueller
Journal:  Rural Policy Brief       Date:  2017-04-01

6.  Opioids, naloxone, and beyond: The intersection of medication safety, public health, and pharmacy.

Authors:  Jeffrey P Bratberg
Journal:  J Am Pharm Assoc (2003)       Date:  2017 Mar - Apr

7.  State legal innovations to encourage naloxone dispensing.

Authors:  Corey Davis; Derek Carr
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-07

8.  The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution.

Authors:  Allison Burrell; Laken Ethun; Jaime Allen Fawcett; Sherry Rickard-Aasen; Karl Williams; Shannon M Kearney; Janice L Pringle
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-19

9.  Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database.

Authors:  Marc L Fleming; Jamie C Barner; Carolyn M Brown; Marvin D Shepherd; Scott Strassels; Suzanne Novak
Journal:  Res Social Adm Pharm       Date:  2013-06-29

Review 10.  Primary care models for treating opioid use disorders: What actually works? A systematic review.

Authors:  Pooja Lagisetty; Katarzyna Klasa; Christopher Bush; Michele Heisler; Vineet Chopra; Amy Bohnert
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

View more
  7 in total

1.  Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability.

Authors:  Robert K Brooner; Kenneth B Stoller; Punam Patel; Li-Tzy Wu; Haijuan Yan; Michael Kidorf
Journal:  Drug Alcohol Depend Rep       Date:  2022-05-16

2.  Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Li-Tzy Wu; William S John; Udi E Ghitza; Aimee Wahle; Abigail G Matthews; Mitra Lewis; Brett Hart; Zach Hubbard; Lynn A Bowlby; Lawrence H Greenblatt; Paolo Mannelli
Journal:  Addiction       Date:  2021-01-11       Impact factor: 7.256

3.  Access to specialty healthcare in urban versus rural US populations: a systematic literature review.

Authors:  Melissa E Cyr; Anna G Etchin; Barbara J Guthrie; James C Benneyan
Journal:  BMC Health Serv Res       Date:  2019-12-18       Impact factor: 2.655

Review 4.  Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.

Authors:  Hannah M Gregory; Veronica M Hill; Robert W Parker
Journal:  Cureus       Date:  2021-11-24

5.  Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.

Authors:  Li-Tzy Wu; William S John; Eric D Morse; Steve Adkins; Jennifer Pippin; Robert K Brooner; Robert P Schwartz
Journal:  Addiction       Date:  2021-08-16       Impact factor: 6.526

6.  Rural-Urban Disparities in Access to Medicaid-Contracted Pharmacies in Washington State, 2017.

Authors:  Janessa M Graves; Demetrius A Abshire; Megan Undeberg; Laura Forman; Solmaz Amiri
Journal:  Prev Chronic Dis       Date:  2020-08-20       Impact factor: 2.830

7.  Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013-2017.

Authors:  Jamey J Lister; Jennifer D Ellis; Miyoung Yoon
Journal:  Addict Behav Rep       Date:  2019-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.